Skip to main content

Advertisement

Log in

Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Meningiomas are principally benign in nature. Some meningiomas, however, grow fast or recur even after total removal. The biological behavior of meningiomas often can not be predicted from conventional histopathological studies. A monoclonal antibody against proliferating cell nuclear antigen (PCNA) was used to investigate the usefulness of the PCNA index as a parameter to estimate the proliferative activity of meningiomas. Fifty-two meningiomas were examined. The mean PCNA index of recurrent meningiomas (3.37±0.92%) was significantly higher than that of non-recurrent meningiomas (1.12±0.51%) (p <0.005). The PCNA indices of recurrent cases were all higher than 2.0%. A semilog linear regression analysis between tumor doubling time and PCNA index showed a significant correlation (r=0.90, p < 0.05). An inverse linear correlation between PCNA index and interval to recurrence was observed (r=0.62, p < 0.05). A good linear correlation was also shown between PCNA index and BUdR labeling index (r = 0.88, p < 0.01). The results of this study suggest that, providing the methods of tissue processing, immunostaining and counting of positive nuclei are unified, the PCNA index is a useful parameter for estimating the biological behavior of meningiomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bravo R, Frank R, Blundell PA, Bravo HM: Cyclin/PCNA in the auxiliary protein of DNA polymerase-delta. Nature 326: 515–517, 1987

    PubMed  Google Scholar 

  2. Bravo R, Bravo HM: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle. Association with DNA replication sites. J Cell Biol 105: 1549–1554, 1987

    PubMed  Google Scholar 

  3. Danova M, Riccardi A, Giordano M, Girino M, Mazzini G, Dezza L: Cell cycle-related protein. A flow cytometric study in human tumors. Biol Cell 64: 23–28, 1988

    PubMed  Google Scholar 

  4. Waseem NH, Lane D: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). J Cell Sci 96:121–129, 1990

    PubMed  Google Scholar 

  5. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22–39, 1957

    Google Scholar 

  6. Grantzner HG: Monoclonal antibody to 5-bromo and 5-iodo-deoxyuridine. A new reagent for detection of DNA replication. Science 218: 474–475, 1982

    PubMed  Google Scholar 

  7. Hoshino T, Nagashima T, Murcovic JA, Wilson CB, Edwards MSB, Gutin PH:In situ cell kinetics studies on human neuroectodermal tumors with bromo-deoxyuridine labeling. J Neurosurg 64: 453–459, 1986

    PubMed  Google Scholar 

  8. Burger PC, Shibata T, Kleihaus P: The use of the monoclonal antibody Ki-67 in the identification of proliferating cells. Application to surgical neuropathology. Am J Surg Pathol 10: 611–617, 1986

    PubMed  Google Scholar 

  9. Gades J, Bocher MHG, Key C, Cattoretti G: Immunohistological detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissue. J Pathol 168: 85, 1992

    PubMed  Google Scholar 

  10. Key G, Bocher MHG, Ducrow M, Schluter C, Gerdes J: New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) prepared against recombinant parts of Ki-67 antigen. Anal Cell Pathol 4: 181, 1992

    Google Scholar 

  11. Robbins BA, Vega D, Ogata K, Tan EM, Nakamura RM: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Acta Pathol Lab Med 111: 841–845, 1987

    Google Scholar 

  12. Al-Sheneber I, Shibata HR, Sampalis J, Jothy S: Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71: 1954–1959, 1993

    PubMed  Google Scholar 

  13. Beppu T, Arai H, Sasaki K: Measurement of PCNA labeling index in astrocytic tumors. No Shinkei Geka 20: 1255–1259, 1992 (in Japanese)

    PubMed  Google Scholar 

  14. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134: 733–739, 1989

    PubMed  Google Scholar 

  15. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections. An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 2285–2294, 1990

    Google Scholar 

  16. Tabuchi K, Honda C, Nakane DK: Demonstration of proliferating cell nuclear antigen (PCNA/cyclin) in glioma cells. Neurol Med Chir (Tokyo) 27: 1–5, 1987

    Google Scholar 

  17. Galand P, Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22: 383–392, 1989

    PubMed  Google Scholar 

  18. Kawakita N, Seki S, Sakagichi H, Yanai A, Kuroki T, Mizoguchi Y, Kobayashi K, Monna T: ANalysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissue from various liver disease fixed in formaldehyde. Am J Pathol 140: 513–520, 1992

    PubMed  Google Scholar 

  19. Landberg G, Roos G: Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell analysis. Cancer Res 51: 4570–4574, 1991

    PubMed  Google Scholar 

  20. Schiffer D, Chio A, Giordana MT, Pezzulo T, Vigliani MC: Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: An immunohistochemical study. Acta Neuropathol 85: 495–502, 1993

    PubMed  Google Scholar 

  21. Allengranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta M, Polio B, Dalla Palma P, Barbareschi M: Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Archiv A Pathol Anat 419: 417–423, 1991

    Google Scholar 

  22. Karamitopoulou E, Perentes E, Melachinou M, Maraziotis T: Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85: 316–322, 1993

    PubMed  Google Scholar 

  23. Nakasu S, Nakajima M, Nioka H, Matsumura K, Handa J: Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index. Neurol Med Chir (Tokyo) 34: 269–273, 1994

    Google Scholar 

  24. Chan RC, Thompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningiomas: Retrospective study in 257 cases. J Neurosurg 60: 52–60, 1984

    PubMed  Google Scholar 

  25. Giombini S, Solero CL, Morello G: Late outcome of operations for supratentorial convexity meningiomas: Report of 2–7 cases. Surg Neurol 22:588–594, 1984

    PubMed  Google Scholar 

  26. Jaaskelainen J: Seemingly complete removal of histologically benign intracranial meningioma: Late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:165–172, 1985

    Google Scholar 

  27. Waga S, Yamashita J, Handa H: Recurrence of meningiomas. Neurol Med Chir (Tokyo) 17: 203–208, 1977 (in Japanese)

    Google Scholar 

  28. Yamashita J, Handa H, Iwaki K, Abe M: Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 14: 33–40, 1980

    PubMed  Google Scholar 

  29. Adegbite AB, Khan MI, Paine KWE, Tan LK: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58: 51–56, 1983

    PubMed  Google Scholar 

  30. Boker D-K, Meuer H, Gullota F: Recurring intracranial meningiomas: Evaluation of some factors predisposing for tumor recurrence. J Neurosurg Sci 29: 11–17, 1985

    PubMed  Google Scholar 

  31. Jellinger K, Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 24: 279–298, 1975

    Google Scholar 

  32. Hoshino T, Nagashima T, Murcovic JA, Wilson CB, Davis RL: Proliferative potential of human meningiomas of the brain: A cell kinetics study with bromodeoxyuridine. Cancer 58: 1466–1472, 1986

    PubMed  Google Scholar 

  33. May PL, Broome JC, Lawry J, Buxton RA, Battersby RDE: The prediction of recurrence in meningiomas: A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71: 347–351, 1989

    PubMed  Google Scholar 

  34. Shibata T, Burger PC, Kleihues P: Cell kinetics of human meningiomas: Ki-67 PAP stain. No Shinkei Geka 16: 939–944, 1988 (in Japanese)

    PubMed  Google Scholar 

  35. Orita T, Kajiwara K, Nishizaki T, Ikeda N, Kamiryo T, Aoki H: Nucleolar organizer regions in meningiomas. Neurosurgery 26: 43–46, 1990

    PubMed  Google Scholar 

  36. Zimmer C, Gottschalk J, Cervos-Navarro J, Martin H, Beil M, Jautzke G: Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Path Res Pract 188: 951–958, 1992

    PubMed  Google Scholar 

  37. Pearlman AW: Breast cancer — influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrence. Cancer 38: 1826–1833, 1976

    PubMed  Google Scholar 

  38. Cho KG, Hoshino T, Nagashima T, Murovic J, Wilson CB: Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling. J Neurosurg 65: 790–794, 1986

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakabayashi, H., Sakaguchi, M., Katsuyama, J. et al. Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression. J Neuro-Oncol 24, 209–217 (1995). https://doi.org/10.1007/BF01052837

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052837

Key words

Navigation